Vanitha A Sankaran, MD
Psychiatry · Cupertino
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 8
- 2 carriers
- Office
- 1
Offices
1 location
Plans that list them
8 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sankaran’s office at (408) 705-3537 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
8 of 8 plans
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A106538 · Current
Licensed to practise in California · since 2009 · expires 2028-05-31 · Dr. M.G.R. Medical University, P.S.G. Institute of Medical Sciences.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$13,559
Pharmacies billed $13,559 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 253) in 2024. At or below the middle of the specialty; the typical psychiatry & neurology clinician is at 0%.
239 generic and 14 brand-name prescriptions · $13,559 in drug cost · 22 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Olanzapine | 21 | $405 | $19 |
| Quetiapine | 17 | $195 | $11 |
| Risperidone | 19 | $139 | $7 |
| Gabapentin | 13 | $129 | $10 |
| Trazodone | 17 | $118 | $7 |
See all 6 drugs
| Olanzapine | 21 | $405 | $19 |
| Quetiapine | 17 | $195 | $11 |
| Risperidone | 19 | $139 | $7 |
| Gabapentin | 13 | $129 | $10 |
| Trazodone | 17 | $118 | $7 |
| Sertraline | 13 | $45 | $3 |
Year by year
| 2024 | 253 | 59 | 0% (0) | 6% | $13,559 |
| 2023 | 224 | 61 | 0% (0) | 5% | $7,506 |
| 2022 | 343 | 67 | 0% (0) | 6% | $34,415 |
| 2021 | 338 | 66 | 0% (0) | None | $60,545 |
| 2020 | 398 | 82 | 0% (0) | 8% | $38,690 |
| 2019 | 493 | 78 | 0% (0) | 6% | $38,794 |
| 2018 | 617 | 60 | None | 6% | $41,809 |
| 2017 | 631 | 61 | 0% (0) | 10% | $30,233 |
| 2016 | 607 | 45 | None | 15% | $49,980 |
| 2015 | 340 | 26 | 0% (0) | 20% | $40,963 |
| 2014 | 199 | 16 | 0% (0) | 38% | $23,526 |
| 2013 | 59 | None | 0% (0) | 37% | $2,275 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Olanzapine | 19 | $548 | $29 |
| Lithium Carbonate | 13 | $331 | $25 |
| Gabapentin | 13 | $177 | $14 |
| Quetiapine | 12 | $87 | $7 |
| Sertraline | 11 | $61 | $6 |
2022: 9 drugs
| Aripiprazole | 20 | $1,171 | $59 |
| Risperidone | 20 | $447 | $22 |
| Olanzapine | 24 | $406 | $17 |
| Venlafaxine Hcl Er | 11 | $329 | $30 |
| Lithium Carbonate | 17 | $246 | $14 |
| Gabapentin | 19 | $228 | $12 |
| Trazodone | 17 | $178 | $10 |
| Quetiapine | 11 | $125 | $11 |
| Atorvastatin | 11 | $104 | $9 |
2021: 9 drugs
| Latuda | 12 | $22,192 | $1,849 |
| Duloxetine | 18 | $801 | $45 |
| Olanzapine | 38 | $791 | $21 |
| Aripiprazole | 15 | $477 | $32 |
| Divalproex | 11 | $249 | $23 |
| Trazodone | 19 | $190 | $10 |
| Lithium Carbonate | 13 | $176 | $14 |
| Risperidone | 16 | $156 | $10 |
| Gabapentin | 14 | $99 | $7 |
2020: 11 drugs
| Invega Sustenna | 11 | $22,223 | $2,020 |
| Aripiprazole | 22 | $1,859 | $84 |
| Olanzapine | 42 | $511 | $12 |
| Quetiapine | 31 | $498 | $16 |
| Haloperidol | 11 | $441 | $40 |
| Divalproex | 17 | $326 | $19 |
| Sertraline | 28 | $146 | $5 |
| Hydroxyzine Pamoate | 14 | $131 | $9 |
| Gabapentin | 11 | $125 | $11 |
| Trazodone | 23 | $124 | $5 |
| Risperidone | 15 | $85 | $6 |
2019: 16 drugs
| Invega Sustenna | 11 | $18,626 | $1,693 |
| Aripiprazole | 23 | $1,337 | $58 |
| Olanzapine | 35 | $700 | $20 |
| Risperidone | 44 | $573 | $13 |
| Haloperidol Decanoate | 13 | $504 | $39 |
| Haloperidol | 11 | $391 | $36 |
| Escitalopram | 17 | $333 | $20 |
| Quetiapine | 31 | $318 | $10 |
| Benztropine Mesylate | 24 | $316 | $13 |
| Trazodone | 31 | $225 | $7 |
| Sertraline | 29 | $189 | $7 |
| Duloxetine | 16 | $181 | $11 |
| Buspirone | 13 | $154 | $12 |
| Hydroxyzine | 11 | $102 | $9 |
| Hydroxyzine Pamoate | 11 | $101 | $9 |
| Venlafaxine Hcl Er | 11 | $71 | $6 |
2018: 22 drugs
| Latuda | 15 | $17,491 | $1,166 |
| Chlorpromazine | 13 | $6,134 | $472 |
| Aripiprazole | 27 | $1,956 | $72 |
| Mirtazapine | 28 | $774 | $28 |
| Risperidone | 63 | $747 | $12 |
| Duloxetine | 33 | $668 | $20 |
| Olanzapine | 29 | $493 | $17 |
| Buspirone | 27 | $455 | $17 |
| Ziprasidone | 15 | $419 | $28 |
| Quetiapine | 30 | $388 | $13 |
| Trazodone | 46 | $269 | $6 |
| Sertraline | 49 | $265 | $5 |
| Escitalopram | 13 | $239 | $18 |
| Bupropion Xl | 13 | $226 | $17 |
| Lithium Carbonate Er | 11 | $190 | $17 |
| Benztropine Mesylate | 15 | $159 | $11 |
| Bupropion Hcl Sr | 13 | $156 | $12 |
| Venlafaxine Hcl Er | 26 | $146 | $6 |
| Gabapentin | 13 | $145 | $11 |
| Fluoxetine | 13 | $105 | $8 |
| Clonazepam | 21 | $82 | $4 |
| Paroxetine | 13 | $31 | $2 |
2017: 18 drugs
| Aripiprazole | 23 | $2,807 | $122 |
| Duloxetine | 28 | $1,122 | $40 |
| Buspirone | 22 | $914 | $42 |
| Risperidone | 94 | $740 | $8 |
| Lithium Carbonate Er | 28 | $420 | $15 |
| Quetiapine | 31 | $418 | $13 |
| Bupropion Xl | 16 | $392 | $25 |
| Fluoxetine | 18 | $392 | $22 |
| Olanzapine | 19 | $349 | $18 |
| Mirtazapine | 31 | $328 | $11 |
| Trazodone | 50 | $305 | $6 |
| Benztropine Mesylate | 19 | $271 | $14 |
| Sertraline | 33 | $224 | $7 |
| Paroxetine | 14 | $210 | $15 |
| Gabapentin | 15 | $173 | $12 |
| Escitalopram | 20 | $148 | $7 |
| Clonazepam | 29 | $109 | $4 |
| Citalopram Hbr | 12 | $40 | $3 |
2016: 18 drugs
| Invega Sustenna | 32 | $33,658 | $1,052 |
| Clozapine | 18 | $1,510 | $84 |
| Fluoxetine | 15 | $1,479 | $99 |
| Duloxetine | 21 | $1,211 | $58 |
| Buspirone | 17 | $936 | $55 |
| Divalproex | 15 | $662 | $44 |
| Lithium Carbonate Er | 29 | $649 | $22 |
| Risperidone | 98 | $646 | $7 |
| Bupropion Xl | 22 | $589 | $27 |
| Trazodone | 57 | $386 | $7 |
| Mirtazapine | 28 | $331 | $12 |
| Sertraline | 34 | $282 | $8 |
| Clonazepam | 26 | $274 | $11 |
| Quetiapine | 25 | $264 | $11 |
| Benztropine Mesylate | 23 | $244 | $11 |
| Bupropion Hcl Sr | 17 | $229 | $13 |
| Gabapentin | 15 | $152 | $10 |
| Paroxetine | 14 | $92 | $7 |
2015: 13 drugs
| Invega Sustenna | 14 | $22,093 | $1,578 |
| Duloxetine | 11 | $2,337 | $212 |
| Divalproex | 17 | $549 | $32 |
| Trazodone | 38 | $442 | $12 |
| Lithium Carbonate Er | 18 | $417 | $23 |
| Risperidone | 58 | $373 | $6 |
| Bupropion Xl | 13 | $288 | $22 |
| Benztropine Mesylate | 27 | $260 | $10 |
| Sertraline | 28 | $237 | $8 |
| Clonazepam | 28 | $198 | $7 |
| Mirtazapine | 12 | $193 | $16 |
| Quetiapine | 15 | $179 | $12 |
| Escitalopram | 12 | $54 | $5 |
2014: 6 drugs
| Invega | 13 | $6,925 | $533 |
| Trazodone | 20 | $1,001 | $50 |
| Risperidone | 22 | $311 | $14 |
| Sertraline | 15 | $167 | $11 |
| Clonazepam | 13 | $141 | $11 |
| Benztropine Mesylate | 16 | $117 | $7 |
Money from drug and device companies
$641 in 2019
A payment is not proof that care is biased.
| Neurocrine Biosciences | Ingrezza | $250 | 2 payments
|
| Alkermes | Aristada | $141 | 3 payments
|
| Janssen Pharmaceuticals | None | $125 | 1 payment
|
| Sunovion Pharmaceuticals | Latuda | $125 | 1 payment
|
See all 7 published payments
| Janssen Pharmaceuticals | Meals · 2019-10-10 | None | $125 |
| Neurocrine Biosciences | Meals · 2019-10-03 | Ingrezza | $125 |
| Sunovion Pharmaceuticals | Meals · 2019-08-29 | Latuda | $125 |
| Alkermes | Meals · 2019-05-20 | Vivitrol | $8 |
| Alkermes | Meals · 2019-05-19 | Vivitrol | $8 |
| Alkermes | Meals · 2019-03-26 | Aristada | $125 |
| Neurocrine Biosciences | Meals · 2019-03-06 | Ingrezza | $125 |
Professional record
- NPI
- 1720137391
- Licence
- CA A106538California A106538: Current · expires 2028-05-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 7381 Rainbow Dr, Cupertino, CA, 95014
- NPI first listed
- 2007-01-10
- NPI last updated
- 2013-07-12
This is when the NPI record was last certified, not a medical board exam.